BGM
BGM
NASDAQ · Pharmaceuticals

Bgm Group Ltd

$0.29
+0.01 (+2.38%)
As of May 10, 10:34 PM ET ·
Financial Highlights (FY 2026)
Revenue
611.77M
Net Income
-35,176,084
Gross Margin
16.4%
Profit Margin
-5.8%
Rev Growth
-24.0%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 16.4% 16.4% 33.1% 33.1%
Operating Margin -2.2% -2.0% 16.8% 14.4%
Profit Margin -5.8% -5.5% 11.7% 12.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 611.77M 804.64M 106.35M 109.96M
Gross Profit 100.27M 131.88M 35.22M 36.42M
Operating Income -13,764,778 -16,293,963 17.84M 15.80M
Net Income -35,176,084 -41,639,452 12.42M 13.50M
Gross Margin 16.4% 16.4% 33.1% 33.1%
Operating Margin -2.2% -2.0% 16.8% 14.4%
Profit Margin -5.8% -5.5% 11.7% 12.3%
Rev Growth -24.0% -24.0% +7.5% +6.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 23.86M 26.94M
Total Equity 126.32M 122.05M
D/E Ratio 0.19 0.22
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 18.62M 23.26M 22.69M 21.79M
Free Cash Flow 8.29M 10.61M